China experiences consumer deflation for the third consecutive month, impacted by US tariffs and sagging domestic demand. What does this mean for the global economy?
The Trump administration is reportedly planning to deport Asian immigrants to Libya, a country notorious for human rights abuses. Legal challenges arise as the administration faces scrutiny over this controversial move.
Representative Kat Cammack has introduced the App Store Freedom Act, aiming to allow third-party app stores and payment systems, enhancing competition in the mobile app marketplace. This could transform how users interact with major platforms like Apple and Google.
Rihanna revealed her third pregnancy just hours before the Met Gala, showcasing breathtaking outfits that celebrated her baby bump. A$AP Rocky confirmed the news on the red carpet, making it a night to remember!
In a surprising announcement, former President Trump declares he will not run for a third term in the upcoming 2024 election, stirring speculation about the future of American politics.
In a recent interview, President Trump dismissed the idea of a third term while hinting at possible successors like VP JD Vance and Secretary of State Marco Rubio, emphasizing the need for strong Republican leadership.
In a recent interview, Trump questions due process rights, downplays military action against Canada, and comments on his potential third term. Discover the highlights from his candid conversation!
In a recent interview, Donald Trump expressed uncertainty about upholding immigrant rights while making it clear he plans to leave office after his second term. His remarks raise questions about due process and the future of his political ambitions.
In a surprising statement, Trump categorically denies any plans for a third presidential term, stating, 'Not something I'm looking to do.' This comes as he supports Vance and Rubio for the upcoming elections.
A groundbreaking study reveals semaglutide, already known for weight loss and diabetes treatment, is effective for fatty liver disease, benefiting two-thirds of participants in a recent trial. This could revolutionize treatment options!
